Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 261 followers
Latest posts
Last updated about 13 hours ago
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation...
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation...
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 11, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant...
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 1, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Spedra, avanafil, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 15, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Spedra, avanafil, Date of authorisation...
Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 11, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation...
Human medicines European public assessment report (EPAR): Twynsta, telmisartan,amlodipine, Date of authorisation: 07/10/2010, Revision: 15, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Twynsta, telmisartan,amlodipine, Date of authorisation...
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion